| Literature DB >> 27626051 |
Pathomwat Wongrattanakamon1, Vannajan Sanghiran Lee2, Piyarat Nimmanpipug3, Supat Jiranusornkul1.
Abstract
The data is obtained from exploring the modulatory activities of bioflavonoids on P-glycoprotein function by ligand-based approaches. Multivariate Linear-QSAR models for predicting the induced/inhibitory activities of the flavonoids were created. Molecular descriptors were initially used as independent variables and a dependent variable was expressed as pFAR. The variables were then used in MLR analysis by stepwise regression calculation to build the linear QSAR data. The entire dataset consisted of 23 bioflavonoids was used as a training set. Regarding the obtained MLR QSAR model, R of 0.963, R (2)=0.927, [Formula: see text], SEE=0.197, F=33.849 and q (2)=0.927 were achieved. The true predictabilities of QSAR model were justified by evaluation with the external dataset (Table 4). The pFARs of representative flavonoids were predicted by MLR QSAR modelling. The data showed that internal and external validations may generate the same conclusion.Entities:
Keywords: Flavonoids; Herb-drug interaction; Molecular modelling; Multiple linear regression; P-glycoprotein; QSAR
Year: 2016 PMID: 27626051 PMCID: PMC5011158 DOI: 10.1016/j.dib.2016.08.004
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Molecular structures of bioflavonoids with FAR values (in the parenthesis) of the training set. 1–21 are from Gyémant et al. [1], and 22–23 are from Martins et al. [2].
Correlation matrix indicating intercorrelation among descriptors used in MLR QSAR model.
| RDF_Pi Chg_86 | RDF_SigChg_76 | 3DACorr_TotChg_9 | RDF_LpEN _54 | 3DACorr_PiChg_9 | RDF_SigChg_57 | |
|---|---|---|---|---|---|---|
| RDF_Pi Chg_86 | 1 | |||||
| RDF_SigChg_76 | 0.288 | 1 | ||||
| 3DACorr_TotChg_9 | 0.572 | 0.377 | 1 | |||
| RDF_Lp EN_54 | 0.529 | −0.035 | 0.448 | 1 | ||
| 3DACorr_PiChg_9 | −0.745 | −0.315 | −0.299 | −0.290 | 1 | |
| RDF_SigChg_57 | 0.444 | 0.629 | 0.287 | −0.033 | −0.477 | 1 |
RDF_PiChg_86 is the radial distribution functions weighted by π charges, where r is in the range of 8.5–8.6 Å.
RDF_SigChg_76 is the radial distribution functions weighted by σ atom charges, where r is in the range of 7.5–7.6 Å.
3DACorr_TotChg_9 is the 3D autocorrelation weighted by total atom charges (sum of σ, π charges), where d is in the range of 9–10 Å.
RDF_LpEN_54 is the radial distribution functions weighted by lone pair electronegativities, where r is in the range of 5.3–5.4 Å.
3DACorr_PiChg_9 is the 3D autocorrelation weighted by π atom charges, where d is in the range of 9–10 Å.
RDF_SigChg_57 is the radial distribution function weighted by σ charge, where r is in the range of 5.6–5.7 Å.
The observed and calculated pFAR values using the developed QSAR equation with associated residuals.
| 1 | −1.26 | −1.20 | −0.06 |
| 2 | −1.67 | −1.54 | −0.13 |
| 3 | −0.49 | −0.63 | 0.14 |
| 4 | −0.48 | −0.34 | −0.13 |
| 5 | −0.45 | −0.52 | 0.07 |
| 6 | −1.46 | −1.39 | −0.07 |
| 7 | −0.46 | −0.47 | 0.01 |
| 8 | −0.45 | −0.42 | −0.03 |
| 9 | −0.36 | −0.16 | −0.20 |
| 10 | −1.16 | −1.38 | 0.22 |
| 11 | −0.18 | −0.27 | 0.09 |
| 12 | −0.69 | −0.60 | −0.09 |
| 13 | 0.22 | 0.12 | 0.10 |
| 14 | 0.15 | 0.03 | 0.12 |
| 15 | 0.15 | −0.09 | 0.25 |
| 16 | 0.10 | 0.32 | −0.22 |
| 17 | 0.30 | 0.21 | 0.10 |
| 18 | 0.22 | 0.25 | −0.03 |
| 19 | 0.10 | 0.30 | −0.20 |
| 20 | −0.38 | −0.34 | −0.04 |
| 21 | −1.56 | −1.34 | −0.22 |
| 22 | 0.01 | −0.44 | 0.45 |
| 23 | 0.24 | 0.36 | −0.13 |
Fig. 1A plot of observed (experimental) versus calculated (predicted) pFAR values of the training set.
Comparison between the calculated P-gp modulatory activity values (pFAR) and observed values of 11 flavonoids which exhibited a significant experimental P-gp inhibitory activity expressed by Inhibitory efficiency.
| Naringenin | 56.93 | Active inhibitor | −0.39 | Active inhibitor |
| Quercetin | 72.73 | Active inhibitor | −0.04 | Active inhibitor |
| Morin | 56.63 | Active inhibitor | −0.07 | Active inhibitor |
| Silymarin | 60 | Active inhibitor | 0.42 | Inducer |
| Epigallocatechin gallate (EGCG) | 168.18 | Strong inhibitor | −1.03 | Strong inhibitor |
| Epicatechin gallate (ECG) | 95.45 | Active inhibitor | −0.61 | Active inhibitor |
| Biochenin A | 198.04 | Strong inhibitor | −1.30 | Strong inhibitor |
| Hesperidin | 164.41 | Strong inhibitor | −1.32 | Strong inhibitor |
| Demethylnobiletin | 87.43 | Active inhibitor | −1.13 | Strong inhibitor |
| 5HHMF | 65.47 | Active inhibitor | 0.44 | Inducer |
| Nobiletin | 45.71 | Active inhibitor | 1.58 | Inducer |
| Positive control (verapamil) | 100 | Strong inhibitor | – | – |
Inhibitory efficiency calculated as percentage compared to a positive control; verapamil.
From Chung et al. [10].
From Zhang and Morris [12].
From Kitagawa et al. [11].
From El-Readi et al. [13].
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |